Novel Coronavirus (SARS-CoV-2/COVID-19)
A bipartisan group in the Senate introduced a $908 billion proposal aimed at breaking the stalemate over more COVID-19 relief.
In an open letter to the American public, the AHA, along with the American Medical Association and American Nurses Association, today affirmed their support for vaccines as a critical means for protecting individuals, communities and loved ones from COVID-19, the worst global health crisis in…
As COVID-19 vaccine development continues to progress, leading U.S. medical, nursing and health organizations today affirmed their commitment to ensuring COVID-19 vaccines are evaluated and ultimately authorized through a rigorous scientific and regulatory process.
During the pandemic, health systems were pushed to transform their digital strategies quickly to meet the needs of their patients and communities.
The Centers for Medicare & Medicaid Services (CMS) Nov. 25 announced several flexibilities aimed at allowing health care services to be provided outside of a hospital setting in response to the surging COVID-19 pandemic.
Congress is back in Washington, D.C., and sprinting to the finish line to complete its end-of-the-year work during the “lame-duck” session. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11.
Congress is back in Washington, D.C., and sprinting to the finish line to complete its end-of-the-year work during the “lame-duck” session. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11.
In a study of 156 front-line hospital workers who tested positive for COVID-19 antibodies, 94% had lower antibody levels 60 days later, including 28% whose antibodies fell below the threshold for a positive test result, the Centers for Disease Control and Prevention reported.
Over the next several months, the National Institute of Allergy and Infectious Diseases expects to enroll up to 1,500 adult COVID-19 hospital patients who require supplemental oxygen in a global clinical trial that aims to determine whether baricitinib or dexamethasone is more effective at…
The Centers for Medicare & Medicaid Services has assigned Medicare Severity-Diagnosis-Related Groups to six new ICD-10 diagnosis codes for reporting conditions related to COVID-19 on medical claims effective Jan. 1.